1Amarapurkar DN, Hashimoto E, Lesmana LA, et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol,2007 ,22 :788-793.
2Fan JG, Saibara T, Chitturi S, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol,2007 ,22 :794-780.
3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1518
4Riley P, Sudarshi D, Johal M, et al. Weight loss, dietary advice and statins therapy in non-alcoholic fatty liver disease;a retrospective study. Int J Clin Pract,2008 ,62 :374-81.
5Nair S, Diehl AM, Wiseman M, et al. Mefformin in the treatment of non- alcoholic steatohepatitis;a pilot open label trial. Aliment Pharmaeol Ther, 2004 ; 20 : 23 -28.
6Aithal CP,Thomas JA, Kaye PV,et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology, 2008,135 : 1176-1184.
7Angulo P, Keach JC, Batts KP, et al. Independent Predictors of Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis. Hepatology, 1999, 30 : 1356-1362.
8Fernandez-Miranda C, Prrez-Carreras M, Colina F, et al. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. Dig Liver Dis, 2008,40:200-205.
9Chalasani N. Statins and hepatictoxicity;focus on patients with fatty liver. Hepatology,2005 ,41:690-695.
10Nobili V,Manco M,Ciampalini P,et al. Mefformin use in children with nonalcoholic fatty liver disease ; an open-label, 24-month, observational pilot study. Clin Ther, 2008,30:1168-1176.
5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
